Near the end of the care pathway, some patients may need coordinated follow-up across specialties
FDA-approved peptides like GLP-1 medications have a risk of side effects like nausea, vomiting, constipation, and diarrhea
It is not intended to diagnose, prevent or treat any medical condition
This may result in sense loss, difficulty in proprioception, neuropathic pain, difficulty walking, poor balance, loss of sensation in the feet, muscle weakness, blurred vision (either due to retinopathy [27] or optic neuropathy [28] ), impaired urination, fertility problems, decreased sense of taste and smell, decreased level of consciousness, changes in reflexes, memory loss, mood swings, depression, irritability, cognitive impairment, confusion, anxiety, clumsiness, dementia, and, in more severe cases, psychosis